Enzalutamide for Patients With Androgen Receptor Positive Salivary Cancers

NCT02749903 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

46

Enrollment

OTHER

Sponsor class

Conditions

Salivary Cancer

Interventions

DRUG: enzalutamide

Sponsor

Alliance for Clinical Trials in Oncology

Collaborators

[object Object]
[object Object]